| 000 | 01871 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518100217.0 | ||
| 264 | 0 | _c20210218 | |
| 008 | 202102s 0 0 eng d | ||
| 022 | _a2168-6084 | ||
| 024 | 7 |
_a10.1001/jamadermatol.2020.0796 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDrucker, Aaron M | |
| 245 | 0 | 0 |
_aSystemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis. _h[electronic resource] |
| 260 |
_bJAMA dermatology _c06 2020 |
||
| 300 |
_a659-667 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
| 650 | 0 | 4 |
_aAzathioprine _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 |
_aDermatitis, Atopic _xcomplications |
| 650 | 0 | 4 |
_aDermatologic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xadministration & dosage |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aNetwork Meta-Analysis |
| 650 | 0 | 4 |
_aPruritus _xdiagnosis |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aEllis, Alexandra G | |
| 700 | 1 | _aBohdanowicz, Michal | |
| 700 | 1 | _aMashayekhi, Soudeh | |
| 700 | 1 | _aYiu, Zenas Z N | |
| 700 | 1 | _aRochwerg, Bram | |
| 700 | 1 | _aDi Giorgio, Sonya | |
| 700 | 1 | _aArents, Bernd W M | |
| 700 | 1 | _aBurton, Tim | |
| 700 | 1 | _aSpuls, Phyllis I | |
| 700 | 1 | _aKüster, Denise | |
| 700 | 1 | _aSiegels, Doreen | |
| 700 | 1 | _aSchmitt, Jochen | |
| 700 | 1 | _aFlohr, Carsten | |
| 773 | 0 |
_tJAMA dermatology _gvol. 156 _gno. 6 _gp. 659-667 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jamadermatol.2020.0796 _zAvailable from publisher's website |
| 999 |
_c30886410 _d30886410 |
||